Abstract
The accumulation of misfolded‐aggregated proteins is linked to an increasing number of degenerative diseases, including hypertension. Although protein damage and misfolding are an inevitable consequence of normal cellular function, multiple proteostasis mechanisms are devoted to the repair or clearance of damaged proteins in order to prevent proteotoxicity. Autophagy is the constitutive and basally active recycling mechanism responsible for protein quality control. Previously, our data has suggested decreased autophagy in conduit and resistance arteries from spontaneously hypertensive rats (SHR); however, direct measurement of autophagic activity, as well as the proteotoxic consequences of undegraded, misfolded protein has not been performed. Furthermore, the effects of reconstituting autophagic activity on vascular reactivity are currently unknown. We hypothesized that mesenteric resistance arteries (MRA) from adult (14 weeks old) SHR would have decreased autophagic activity in lysosomes extracted from arteries and this would be associated with increased misfolded protein oligomers. Therefore, we further hypothesized that upregulation of autophagy via mammalian target of rapamycin (mTOR) inhibition would decrease contraction and improve relaxation in isolated MRA from SHR mounted on wire myographs. We observed that the activity of acid phosphatase, the major acid hydrolase in lysosomes, from arterial lysosomes (pooled mesenteric arteries and aorta) was decreased in SHR (μmol/min, Wistar: 0.51±0.06 vs. SHR: 0.24±0.02, p<0.05). This diminished arterial autophagic activity was observed in conjunction with the increased presence of insoluble protein deposition. Specifically, SHR MRA contained increased fibrillar amyloid oligomers, especially along the endothelium monolayer, as indicated by Congo red staining (Figure 1). When autophagy was reconstituted in isolated MRA via mTOR inhibition with Everolimus (EV; first generation mTOR inhibitor) for 1 hr, we observed that the maximum contraction to phenylephrine was reduced [Emax (mN), Vehicle: 19.8±0.5 vs. EV (0.1 nM): 10.7±0.5 vs. EV (0.1 μM): 8.5±1.0, p<0.05] and the contraction to high concentrations acetylcholine was prevented [LogEC50, Vehicle: −6.9±0.1 vs. EV (0.1 nM): −9.2±0.4 vs. EV (0.1 μM): −8.2±0.1, p<0.05]. Overall, these data reveal that SHR have impaired arterial lysosomal activity and this is associated with the accumulation of misfolded proteins. As a result, reconstituting arterial autophagic activity improved vascular function and could be a novel therapeutic treatment for proteotoxicity in hypertension.Support or Funding InformationNIH (K99GM118885 and P01HL134604).This abstract is from the Experimental Biology 2018 Meeting. There is no full text article associated with this abstract published in The FASEB Journal.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.